Cancer Research Society

402 - 625 President-Kennedy Avenue
Montreal , QC H3A 3S5
President & CEO: Andy Chabot
Board Chair: Domenic Pilla

Charitable Reg. #: 11915 3229 RR0001
Sector: Health - Cancer
Public Foundation

Donor Accountability

Grade: B+

The grade is based on the charity's public reporting of the work it does and the results it achieves.

Financial Transparency

Audited financial statements for current and previous years available on the charity's website [ Audited financial statement for most recent year ]

Need for Funding

Funding Reserves Program Costs

Spending Breakdown

Cents to The Cause

2014 2015 2016
For a dollar donated, cents funding the cause after fundraising and admin costs, excluding surplus.

Full-time staff #22

Avg. Compensation $77,579

Top 10 Staff Salary Range

$350k + 0
$300k - $350k 0
$250k - $300k 0
$200k - $250k 0
$160k - $200k 1
$120k - $160k 1
$80k - $120k 4
$40k - $80k 4
< $40k 0
Information from most recent CRA Charities Directorate filings for F2016

About Cancer Research Society:

Founded in 1945, the Cancer Research Society (CRS) focuses on funding research on the prevention, detection and treatment of the many forms of cancer. The goal of CRS is to fund innovative projects in cancer research. It works closely with academics and principal investigators, supporting scientific research at the academic level. CRS granted $13.8m to 172 research projects of which 12% concerned underfunded cancers. The average operational grant is $120k disbursed over a period of two years. CRS is extremely transparent with its grants, hosting a publicly-available grant database on its website. 

CRS had 97 reviewers contribute to evaluating 384 applications for operating grants. The committee approved grants to over 100 different research teams. The scientific direction of CRS is led by the Scientific Advisory Committee, comprised of 9 members and led by Dr. Ivan Robert Nabi. Supported research explores the causes of cancer and the mechanisms behind the development of cancer cells, among others. Since 2006, the charity has increased its focus on environment and lifestyle elements that increase the risk of cancer. 

Cancer Research Society works closely with universities and research centers, funding 35 bodies in F2016. It is a member of the Canadian Cancer Research Alliance, an alliance that seeks unity among cancer research funders in Canada. In April 2016, Cancer Research society donated $1m to Exactis, a national non-profit, to advance personalized medicine in cancer treatment. 

Financial Review:

Cancer Research Society is one of Canada's Major 100 charities. It received donations of $19.6m in F2016. Administrative costs are 10% of revenues and fundraising costs are 32% of donations. For every dollar donated, 58 cents goes to the cause falling below Ci’s reasonable range. CRS has $14.2m committed to multi-year research grants and fellowships for 2017 and 2018, a recommended practice for scientific research grants. CRS has total funding reserves of $31.2m that can cover 2.3 years of program costs.

This charity report is an update that is being reviewed by Cancer Research Society. Changes and edits may be forthcoming.

Updated on May 16, 2017 by Josh Lam. 

Financial Ratios

Fiscal year ending August
Administrative costs as % of revenues 9.6%7.7%8.9%
Fundraising costs as % of donations 32.0%26.9%29.8%
Program cost coverage (%) 225.8%250.6%259.7%

Summary Financial Statements

All figures in $000s
Donations 19,59222,01819,080
Investment income 1,9432,2243,375
Total revenues 21,53424,24222,455
Program costs 000
Grants 13,82212,61710,619
Administrative costs 1,8741,7031,692
Fundraising costs 6,2645,9315,681
Cash flow from operations (425)3,9914,463
Funding reserves 31,21431,61927,582
Note: Ci has shifted administrative expenses from grants allocated to report administrative expenses separately, increasing administrative expenses (decreasing grants allocated) by $299k in F2016, $309k in F2015, and $269k in F2014.  

Comments added by the Charity:

The mission of the Cancer Research Society is to fund research on all types of cancer throughout Canada. Through its operating grant program, the Society primarily supports fundamental or basic research. Fundamental research answers the why, what and how of cancer. It leads to essential knowledge that serves as the cornerstone for innovative discoveries. The Society also funds translational research, which takes discoveries from the laboratory and brings them to the patient in the form of better diagnostic tools and treatments. Last but not least, the Society, finances projects aimed at understanding the environmental causes of cancer, a field in which it is considered to have played a pioneering role in Canada.

With the goal of expanding its research portfolio and leveraging donor funds, the Cancer Research Society partners with individuals, families, groups, and other cancer organizations by creating scientific alliances and targeted Research Funds. These partnerships allow enhanced funding of research on:

  • various types of cancer (prostate, breast, pancreas, lung, ovary, myeloma, non-Hodgkin lymphoma, etc.);
  • late effects of childhood cancer treatments;
  • personalized medicine; and the
  • environmental causes of cancer.

In addition to operating grants, and through its Scholarships for the Next Generation of Scientists program, the Society provides young researchers with the opportunity to pursue their careers in Canada. This unique and innovative funding initiative serves to prevent an exodus of our best scientific minds.

During the past five years, the Society has invested $62.3 million in research and has funded 335 new research projects on cancer throughout Canada.

The Cancer Research Society has been funding research since 1945. Since its creation, there have been many advances in cancer detection, prevention and treatment. Guided by the highest standards and an uncompromising commitment, the Society aims to exceed expectations in research. 

For more information:

Comment received October 28, 2016

Go to top